Clinical Trial Update: 24GUT540 : Meeting of Breast Cancer Patients and Pathologists [NA]

View source ↗

Summary

Clinical trial NCT07040514 (24GUT540) related to breast cancer is currently recruiting, with a meeting for breast cancer patients and pathologists.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 24GUT540

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Breast Cancer | NA | Status: RECRUITING